PE20000887A1 - Equipo anticonceptivo de tipo "solo progestageno" que permite un buen control del ciclo - Google Patents

Equipo anticonceptivo de tipo "solo progestageno" que permite un buen control del ciclo

Info

Publication number
PE20000887A1
PE20000887A1 PE1999000799A PE00079999A PE20000887A1 PE 20000887 A1 PE20000887 A1 PE 20000887A1 PE 1999000799 A PE1999000799 A PE 1999000799A PE 00079999 A PE00079999 A PE 00079999A PE 20000887 A1 PE20000887 A1 PE 20000887A1
Authority
PE
Peru
Prior art keywords
progestagen
cycle control
good cycle
allows good
type contraceptive
Prior art date
Application number
PE1999000799A
Other languages
English (en)
Spanish (es)
Inventor
Petrus Gustaaf Wilhelmus Stokman
Gerardus Herman Vitus Korver
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PE20000887A1 publication Critical patent/PE20000887A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PE1999000799A 1998-08-11 1999-08-09 Equipo anticonceptivo de tipo "solo progestageno" que permite un buen control del ciclo PE20000887A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98202699 1998-08-11

Publications (1)

Publication Number Publication Date
PE20000887A1 true PE20000887A1 (es) 2000-09-15

Family

ID=8234025

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000799A PE20000887A1 (es) 1998-08-11 1999-08-09 Equipo anticonceptivo de tipo "solo progestageno" que permite un buen control del ciclo

Country Status (3)

Country Link
AU (1) AU5619399A (fr)
PE (1) PE20000887A1 (fr)
WO (1) WO2000009136A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9180131B2 (en) 2008-12-12 2015-11-10 Laboratoire Hra Pharma Method for contraception
AU2010237120B8 (en) * 2009-04-14 2015-11-26 Laboratoire Hra-Pharma Method for on-demand contraception
EP2730284A1 (fr) * 2012-11-12 2014-05-14 Naari AG Composition uniquement à base de levonorgestrel pour contraception orale optimisée avec contenu de lévonorgestrel défini, posologie et préparation pharmaceutique
US11679114B2 (en) 2021-07-26 2023-06-20 Navad Life Sciences Pte Progestogen-only oral contraception

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4066757A (en) * 1973-03-26 1978-01-03 Ortho Pharmaceutical Corporation Oral contraceptive regimen
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel

Also Published As

Publication number Publication date
AU5619399A (en) 2000-03-06
WO2000009136A1 (fr) 2000-02-24

Similar Documents

Publication Publication Date Title
EA200600964A1 (ru) Фармацевтический препарат для непрерывного гормонального лечения в течение периода времени более длительного, чем 21-28 дней, включающий две композиции эстрогена и/или прогестина
PE20060485A1 (es) Regimenes anticonceptivos con antagonistas del receptor de progesterona y kits
ES2190472T3 (es) Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno.
CA2468748A1 (fr) Contraceptifs oraux pour eviter les grossesses et diminuer la symptomatologie premenstruelle
BR9916579A (pt) Contraceptivo oral trifásico
AR031563A1 (es) Una composicion farmaceutica para emplear en el tratamiento de trastornos menopausicos o posmenopausicos de estrogenos y acetato de medroxiprogesterona, una unidad de dosificacion farmaceutica y uso de una combinacion de estrogenos conjugados y acetato de medroxiprogesterona para la manufactura de u
PL182544B1 (pl) Zestaw do antykoncepcji hormonalnej
ES2116804T3 (es) Preparado polifasico para la anticoncepcion basado en estrogenos naturales.
CY1108093T1 (el) Συστημα παραδοσης φαρμακων που αποτελειται απο τετραϋδροξυλιοποιημενο οιστρογονο για χρηση στην ορμονικη αντισυλληψη
ES2158988T3 (es) Composiciones de aerosol.
BR9813262A (pt) Terapia de progestina com sangramento controlado
TR199802705T2 (xx) Progestojen-anti-progestojen k�r�
KR920011514A (ko) 프로게스토겐만을 함유하는 피임제
KR970704451A (ko) 기능부전성 자궁출혈 치료용 약제의 제조에 유용한 프로게스테론 길항제(Progesterone Antagonists Useful for Preparing Medicaments for Treating Dysfunctional Uterine Bleeding)
ES2348038T5 (es) Preparado polifásico para la contracepción sobre la base de un estrógeno natural
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
NO20061937L (no) Utvidet trefaseprevansjonskur
PE20000887A1 (es) Equipo anticonceptivo de tipo "solo progestageno" que permite un buen control del ciclo
KR920019350A (ko) 자기면역질환요법을 위한 약제조성물
ES2105923B1 (es) Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv).
PE20070555A1 (es) Uso de valerato de estradiol en combinacion con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral
NZ504351A (en) Contraceptive kit comprising progestogen and anti-progestogen and use in treating bleeding induced by a progestogen-only contraceptive regimen
UY26966A1 (es) Uso de antiprogestinas para la inducción de apoptosis en una célula
ECSP993091A (es) Regimen anticonceptivo del tipo "solo progestageno" que permite un buen control del ciclo y eficacia anticonceptiva, donde se suministra el progestageno en dos fases
KR960700726A (ko) 수정의 방지 또는 억제방법(method of preventing of inhibting fertilization)

Legal Events

Date Code Title Description
FC Refusal